2719793-91-4
Chemical Structure
(R)-lunresertib
Synonym(s): (R)-RP-6306
- CAS No.: 2719793-91-4
- Formula:C18H20N4O2
- Molecular Weight:324.38
IUPAC Name: N-(2-(2-(2-(2-((4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)amino)ethoxy)ethoxy)ethoxy)ethoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide
InChIKey: ARBRHWRTXPWZGN-UHFFFAOYSA-N
SMILES: O=C(C1=C(N)[N@]([C@]2=C(C)C=CC(O)=C2C)C3=NC(C)=C(C)C=C31)N
Biological Activity: (R)-lunresertib ((R)-RP-6306) (compound 183) is a membrane-associated tyrosine- and threonine-specific cdc2 inhibitory kinase (Myt1/PKMYT1) inhibitor with an IC50 of 1360 nM. (R)-lunresertib is applicable to Myt1-mediated cancer-related research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(R)-lunresertib | 99.72% | (R)-lunresertib ((R)-RP-6306) (compound 183) is a membrane-associated tyrosine- and threonine-specific cdc2 inhibitory kinase (Myt1/PKMYT1) inhibitor with an IC50 of 1360 nM. (R)-lunresertib is applicable to Myt1-mediated cancer-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
